GlassScriptPhysician profile
Jody Brown
NPI 1306487566
$843.38
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $700 · 2022: $143.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $285.46 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $136.72 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $57.51 | 2021 | |
| Amgen INC. | $52.01 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $45.00 | 2021 | |
| Novo Nordisk INC | $44.04 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $43.81 | 2021-2022 | |
| Nestle Healthcare Nutrition INC. | $40.18 | 2021 | |
| Lilly USA, LLC | $26.45 | 2021 | |
| Sanofi-Aventis U.S. LLC | $25.22 | 2021 | |
| Biodelivery Sciences International, INC. | $25.21 | 2021 | |
| Boston Scientific Corporation | $17.58 | 2021 | |
| Harmony Biosciences LLC | $16.09 | 2021 | |
| Glaxosmithkline, LLC. | $14.08 | 2021 | |
| Pfizer INC. | $14.02 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jody Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.